Global prevalence of polypharmacy among the COVID-19 patients: a comprehensive systematic review and meta-analysis of observational studies

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

Matthew J. Page, Joanne E. McKenzie, Patrick M. Bossuyt et al. · BMJ · 2021 · 83.2K citations · Full text

Counseling, Family Medicine, Systematic Literature Study +19

The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

Alexander E. Gorbalenya, Susan C. Baker, Ralph S. Baric et al. · Nature Microbiology · 2020 · 7.7K citations · Full text

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

Yeming Wang, Dingyu Zhang, Guanhua Du et al. · The Lancet · 2020 · 3.6K citations · Full text

Treatment And Prevention, Covid-19 Pandemic, Clinical Trials +9

Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection

Adam Bernheim, Xueyan Mei, Mingqian Huang et al. · Radiology · 2020 · 2.8K citations · Full text

Advanced Lung Disease, Viral Diagnostics, Covid-19 Epidemiology +20

Newcastle-Ottawa Scale: comparing reviewers’ to authors’ assessments

Carson K. L. Lo, Dominik Mertz, Mark Loeb · BMC Medical Research Methodology · 2014 · 2.3K citations · Full text